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Objectives: To determine the accuracy of contrast-enhanced MRI in the diagnosis and detection of breast lesions 
and their malignant potential by taking the gold standard of histopathology. 
 
Materials and Methods: This study was conducted at the Department of Diagnostic Radiology, Pakistan Institute 
of Medical Sciences (P.I.M.S.) Islamabad. It was undertaken in collaboration with the Department of General 
Surgery P.I.M.S, Department of Pathology P.I.M.S Islamabad, and HIT Hospital Taxila. The study design was a 
cross-sectional (Validation) study and the duration of the study was 6 months (from 01-Oct-2016 to 31-Mar-2017). 
  
Results: Sample size was calculated by using sensitivity and specificity calculator taking sensitivity 94%1 with a 
precision of 6%, specificity 85%1 with a precision of 10%, prevalence is 45.9%2, and confidence interval of 95% it 
comes out to be 92%. Sample collection was made by the technique of Consecutive non-probability sampling. 
 
Conclusion: Breast MRI imaging is a modern evolving modality. A gradual increase in diagnostic specificity is 
achieved with improved software and techniques. More such studies would help develop confidence in this 
advanced imaging modality for improving patient management and avoiding unnecessary biopsies. 
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Introduction 
 
Breast cancer is the most common cancer in women 
being the second leading cause of death in women 
living in the developed world.1 The average 5 years 
survival rate from breast cancer is 57% in the 
developing countries and 73% in the developed 
countries.   
Around a million fresh cases of breast cancer are 
yearly diagnosed globally. It is the most commonly 
diagnosed cancer in females with a frequency of one in 
nine in the Pakistani population. This occurrence is 2.5 
times higher than Iran and India being direct 
neighbourhood countries. Report from Shaukat 
Khanum Memorial Cancer hospital and research 
centre shows that currently, the incidence of breast 
cancer is 45.9% among female patients and 21.5% 
among all. 
The gold standard for screening breast cancer is 
Mammography providing the high two-dimensional 
resolution (2D). Due to its limitations, three-
dimensional structure in a single plane (3D) can be 
achieved by sonomammography or dynamic contrast-
enhanced (DCE)-MRI of the breast. Secondary imaging 
is mandatory whenever there is a suspicious lesion 
found on conventional mammography.  
Sonomammography gives useful insight in detecting 
tissue composition and providing additional 
information on dense breasts and cystic mass lesions. 
MRI of the breast however is superior to both 
conventional and Sonomammography being able to 
image the entire breast in thin slices comprising the 
entire breast volume and measuring differences in 
contrast uptake providing information about the 
vascular nature of breast lesions. Malignant lesions 
generally have a more profound blood supply but 
neovascularity has poor and leaky formation hence 
contrast take-up is different from benign lesions. 
Radiologists can hence distinguish different contrast 
kinetics of malignant and benign lesions leading to 
better differential diagnosis. 
The hallmark of MRI for breast imaging is 
enhancement pattern2 with gadolinium contrast. So 
comparing with other imaging modalities like 
mammography MRI supplies both morphology and 
vascularity (kinetics) of the tumour, increasing its 
sensitivity in the detection of malignancy. Early uptake 
and early washout is a typical pattern of malignant 
lesions. Images are typically taken at 45 seconds of 
gadolinium injection and then every one to two 
minutes, completing by 4 minutes to observe a rapid 
enhancement of malignant breast lesions. 
Breast magnetic resonance imaging (MRI) can be used 
as a screening tool in young women with high-risk 
factors for breast cancer. It has a determining role in 
the estimation of the local staging of cancer and 
response to neoadjuvant chemotherapy. MR Breast can 
also help in evaluating borderline lesions classified so 
by Core needle biopsy.3 For lesions having non-
suspicious enhancement patterns or remaining 
unenhanced at breast MR imaging, follow-up scanning 
may be pursued instead of biopsy. Further 
advancements in DCE-MR imaging with higher-
temporal-resolution and onerous quantitative analyses 
of the temporal enhancement curves4 are recently a 
research avenue. 
This study aims to discuss potential uses of contrast-
enhanced MRI of the breast, in detecting malignant 
breast lesions as they are the most frequently 
diagnosed cancers among Pakistani females. It is a 
non-invasive imaging modality with no ionizing 
radiation. As it is not routinely used as a primary 
diagnostic modality here in Pakistan its diagnostic 
accuracy in detection of malignant and benign breast 
lesions requires to be established to prove or disprove 
its superiority in comparison with mammography and 
ultrasound. There will be an increased public 
awareness regarding this common and manageable 
disease.5,6 
 
Materials and Methods 
 
After taking approval from the institutional review 
board and ethics committee, this study was conducted 
at the Department of Diagnostic Radiology, Pakistan 
Institute of Medical Sciences (P.I.M.S.) Islamabad. It 
was undertaken in collaboration with the Department 
of General Surgery P.I.M.S, Department of Pathology 
P.I.M.S Islamabad, and HIT Hospital Taxila. The study 
design was a cross-sectional (Validation) study and the 
duration of the study was 6 months (from 01-Oct-2016 
to 31-Mar-2017). By using sensitivity and specificity 
calculator taking sensitivity 94%(1) with a precision of 
6%, specificity 85%(1) with a precision of 10%, 
prevalence is 45.9%(2), and confidence interval of 95% 
a minimum of 92 patients were required as the sample 
size. The sampling Technique was Consecutive non-
probability sampling. 
During the study period female patients aged 20 to 60 
years who had the suspicion of breast cancer based on 
clinical examination (having palpable lump with 
irregular margins, fixed to the chest wall, and 
associated skin edema.), Ultrasound features (taller 
than wider hypoechoic lesion with irregular margins, 
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increased vascularity on color Doppler). And/ or 
Mammographic abnormality (hyperdense lesion with 
speculated margins, architectural distortion, 
microcalcifications, associated skin thickening) were 
included. Those excluded were patients with known 
breast malignancy on biopsy, with recent breast 
surgery and radiotherapy (within 6 months of MRI.), 
with recurrence of the disease, and Claustrophobic 
patients unable to undergo MR scanning. 
After obtaining written and informed consent, patients 
were booked for dynamic contrast-enhanced MR 
imaging of both breasts on a 1.5-tesla magnet by using 
a dedicated bilateral breast surface coil. The procedure 
and protocol of the examination were explained to the 
patient and it was declared clearly that it is a research 
study. Demographic features were recorded on the 
Performa by me. An ethical code of conduct was 
maintained and a female chaperone or doctor was 
present for female patients at the time of imaging. The 
scans were viewed by a single consultant radiologist at 
P.I.M.S. diagnostic radiology department. The 
patient’s course of management was meticulously 
followed by the trainee researcher till the biopsy is 
performed and sent to departments of pathology for 
histopathology. Histopathological diagnosis was then 
be correlated with the findings of the contrast-
enhanced MRI breast. 
The data were analyzed in SPSS version 10. A 2 x 2 
table was used to determine sensitivity, specificity, 
positive predictive value, negative predictive value, 
and diagnostic efficacy. Mean for numerical data like 
age and frequency percentages for categorical data like 
a true positive, true negative, false positive, and false 




An aggregate of 92 patients was analysed for 
determining the accuracy of contrast-enhanced MRI as 
a diagnostic tool in detecting malignant breast lesions 
by taking the gold standard of histopathology.  The 
results were analysed as follows:   
Age variation among 92 analysed patients was as, 
31(34%) patients in the age range 31-40 years, 44(48%) 
patients in the age range 41-50 years, 17(18%) patients 
in the age range 51-60 years. The mean age of subjects 
was 42 years, SD being ± 2.16. (Table 1)   
Histopathology findings among 92 patients were 
analysed as 89(97%) patients had malignant lesions 
while 3(3%) patients didn’t have malignant lesions 
(Table 2)   
MRI findings among 92 patients were analysed as 
83(90%) patients had malignant lesions while 9(10%) 
patients didn’t have malignant lesions (Table 3) 
Accuracy of diagnosis of MRI with Histopathology 
taken as the gold standard was analyzed. MRI had a 
sensitivity of 92%, Specificity of 67%, Positive 
predictive value (PPV) of 99%, Negative predictive 
value (NPV) of 22%, and Diagnostic accuracy of 91%. 
(Table 4) 
Table 1: Age Distribution (n=92) 
Age Frequency Percentage 
31-40 years 31 34% 
41-50 years 44 48% 
51-60 years 17 18% 
Total 92 100% 
Mean age was 42 years with SD ± 2.16 
 
Table 2: Malignant Lesions on Histopathology 
(n=92) 
Histopathology Frequency Percentage 
Present  89 97% 
Absent  3 3% 
Total 92 100% 
 
Table 3: Malignant Lesions on MRI (n=92) 
MRI Frequency Percentage 
Present  83 90% 
Absent  9 10% 
Total 92 100% 
 
Table 4: MRI vs. Histopathology Findings (n=92) 
 Histopathology  
Positive  Negative  Total 










 Total 89(97%) 3(3%) 92(100%) 
Sensitivity= 82/82+7*100 = 82/89*100= 92% 
Specificity= 2/2+1*100 = 2/3*100= 67% 
Positive predictive value= 82/82+1*100 = 82/83*100= 
99% 
Negative predictive value= 2/7+2*100 =2/9*100= 22% 




Breast cancer is the most common cancer in women 
being the second leading cause of death in women 
living in the developed world. Around a million fresh 
cases of breast cancer are yearly diagnosed globally. It 
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is the most commonly diagnosed cancer in females 
with a frequency of one in nine in the Pakistani 
population. This occurrence is 2.5 times higher than 
Iran and India being direct neighborhood countries. 
Report from Shaukat Khanum Memorial Cancer 
hospital and research center shows that currently, the 
incidence of breast cancer is 45.9% among female 
patients and 21.5% among all. Approximately 10 fold 
variation is seen among different countries of the 
world in incidence of breast cancer. 
Malta and Cyprus have the highest age-related 
mortality (29.6 per 100,000 population) for breast 
cancer, while Haiti has the lowest mortality (2.0 per 
100,000 population).7 Generally the incidence rates are 
higher in Europe and lower in Africa and Asia.8 The 
commonest cancer in women in the UK remains Breast 
cancer and it accounts for 31% of the reported cases.9 
Impending risk for the immigrant women from low to 
high-risk countries also shows an ascending trend 
depicting a relation with environmental factors, 
lifestyle10 and dietary and drug habits. 
In the last decade of the twentieth century, the use of 
hormone replacement therapy (HRT) was increase and 
is proposed to have a contribution to increasing 
incidences of breast cancer.11 Under the age of 50 and 
premenopausal women at the time of diagnosis of 
breast cancer are less likely to having ER/ PR-positive 
lesions. On contrary, postmenopausal and older 
females usually have breast cancers responding to 
hormonal therapy. The consolidated magnitude of 
propensity from chemotherapy is less than that seen in 
premenopausal or younger women.12,13 The Aromatase 
Inhibitors (AIs)  are evaded customarily in younger 
females due to concerns regarding diminished 
feedback of oestrogen on the pituitary and 
hypothalamus leading to increased Gonadotropin 
secretion and ovarian stimulation, causing increased 
androgen substrate and aromatase.14,15,16 
In our study mean age was 42 years with SD ± 2.16 
with 34% patients in the age range 31-40 years, 48% 
patients in the age range 41-50 years, and 18% patients 
in the age range 51-60 years. According to 
histopathology findings, 97% of patients had 
malignant lesions while 3% of patients didn’t have 
malignant lesions. According to MRI findings, 90% of 
patients had malignant lesions while 10% of patients 
didn’t have malignant lesions. Accuracy of breast MRI 
in diagnosis with the gold standard of Histopathology 
show MRI having a sensitivity of 92%, Specificity of 
67%, Positive predictive value (PPV) of 99%, Negative 
predictive value (NPV) of 22%, and Diagnostic 
accuracy of 91.  
A study conducted at The Johns Hopkins University 
further made use of kinetic curve type assessment in 
conjunction with high-resolution 3D breast MRI 
offering improvement in the diagnostic performance 
of Diagnostic MRI.17 
Diagnostic sensitivity of breast MR in detecting breast 
cancer is high approaching almost 100% for invasive 
malignant lesions. Nevertheless, the specificity varies 
between 37-70% and hence is comparatively low.18 
Factors leading to this wide range of specificity 
depend on differences in the study population, 
machine sophistication, applied protocols, and criteria 
for interpretation. Several studies conducted in the 
past should be consulted for improving the 
specificity.19 
In a study conducted by Siegman et al20, it was 
demonstrated that both qualitative and quantitative 
lesion characteristics were required for diagnostic 
identification of the lesion. Another study conducted 
by Khatri et al21 it was shown that better specificity 
could be gained by quantifying the pattern of 
enhancement. This method however utilised complex 
analysis involving mathematical formulations. We 
demonstrated in our study that the physical 
appearance of the lesion, post-contrast enhancement, 
and qualitative assessment of time signal intensity 
curves are pertinent imaging parameters for MRI 
evaluation in increasing diagnostic confidence. Our 
results are hence consistent with major previous 
studies.22,23 MR imaging is in progressing phase in 
most clinical setups in Pakistan. Our results are 
relatable to many previous studies but still, we have 
several limitations. This is because of the cost factor 
and lack of awareness regarding the usefulness of MR 
imaging for the diagnosis of breast cancer.  It is needed 
that more such studies are carried out in the Pakistani 





Our study concludes that MRI breast is an emergent 
diagnostic modality. The major drawback of this non-
invasive tool was its decreased specificity for 
malignant breast lesions. Various studies have 
nevertheless demonstrated that with better equipment 
and refined techniques the specificity shows a gradual 
increase. Further similar studies are required for 
establishing affirmation. This developing diagnostic 
tool if carefully utilized can help in for improved 
management of patients and reduce the load of 
unneeded biopsies. 
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